Pharmaceuticals

Kcentra Market Expansion Forecast Reaching $2.88 Billion By 2030 At 13.1% CAGR

May 5, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Kcentra Market Projected To Reach By 2030?

Historical expansion was driven by extensive utilization of warfarin, the elevated bleeding susceptibility in patients on anticoagulants, the prompt embrace of PCC products, the urgent requirements of emergency departments, and the imperative for surgical safety within hospitals.

Projected growth is primarily driven by factors such as an increasing elderly demographic requiring anticoagulants, an uptick in urgent surgical interventions, enhanced understanding of the advantages of PCC, the proliferation of trauma care facilities, and a rise in the number of outpatient surgeries. Key trends anticipated during this period encompass a growing need for swift reversal of anticoagulation, advancements in managing hemostasis in emergency situations, the broadening availability of therapies for controlling surgical bleeding, more frequent application in trauma and critical care settings, and the reinforcement of coagulation protocols within hospitals.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20122&type=smp

Which Key Drivers Are Affecting The Kcentra Market Development?

The increasing occurrence of bleeding disorders is anticipated to propel the kcentra market in the future. These disorders, which include conditions like hemophilia, von Willebrand disease (VWD), and acquired coagulopathies, are characterized by an impaired ability of the blood to clot, resulting in extended or excessive bleeding. The growing prevalence of such disorders stems from genetic elements, enhanced diagnostic techniques, and heightened awareness, leading to improved case identification globally. Kcentra, a type of prothrombin complex concentrate, is utilized in addressing bleeding disorders, especially for patients on vitamin K antagonists or those experiencing warfarin-associated bleeding. For example, in December 2023, the World Bleeding Disorders Registry, as reported by the Canada-based World Federation of Hemophilia, documented data from 13,343 individuals with hemophilia across 119 treatment centers in 44 countries in 2023, an increase from 12,296 individuals across 108 centers in 42 countries in 2022. Consequently, the rising prevalence of bleeding disorders acts as a significant driver for the kcentra market. Expanding healthcare expenditure is projected to boost the kcentra market moving forward. Healthcare expenditure encompasses all spending on health-related services, covering investments in medical infrastructure, advanced therapeutic options, emergency services, and surgical procedures. The rise in healthcare expenditure can be attributed to several factors such as an aging population, the prevalence of chronic diseases, elevated service costs, increased demand, technological advancements, rising drug prices, the impact of COVID-19, medical inflation, and income polarization. Regarding Kcentra, healthcare spending is primarily directed towards treatments for the urgent reversal of anticoagulant-induced bleeding, incurring substantial costs when used in critical care and hospital environments. For instance, in May 2024, a report from the UK-based government agency, the Office for National Statistics, indicated that total healthcare expenditure saw a nominal increase of 5.6% from 2022 to 2023, compared to a 0.9% growth rate in 2022. Furthermore, overall long-term health and social care expenditure grew by 2.8% in real terms in 2022. Therefore, the escalating healthcare expenditure is a driving force for the kcentra market.

How Are Different Segments Classified In The Kcentra Market Segment Analysis?

The kcentra market covered in this report is segmented –

1) By Indication: Urgent Reversal Of Warfarin Therapy, Treatment Of Acquired Coagulation Factor Deficiency, Management Of Major Bleeding Events

2) By Formulation: Injectable Formulation, Lyophilized Powder For Reconstitution

3) By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients

4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Outpatient Surgical Centers, Emergency Departments, Specialty Clinics

What Trends Are Influencing The Evolution Of The Kcentra Market?

A significant trend within the kcentra market is the approval of innovative therapies like balfaxar, which is driving competitive progress throughout the industry. Balfaxar is a treatment specifically formulated for the immediate reversal of acquired coagulation factor deficiency induced by warfarin therapy in adult patients who require urgent surgery or invasive medical procedures. For instance, in July 2023, Octapharma USA, a pharmaceutical company based in the US, declared that Balfaxar (prothrombin complex concentrate, human-lens, also referred to as octaplex in Europe and Canada) had received approval from the U.S. Food and Drug Administration (FDA) for the emergency reversal of acquired coagulation factor deficiency caused by vitamin K antagonist (VKA, such as warfarin) therapy in adult patients necessitating urgent surgery or invasive procedures. Balfaxar functions by restoring blood coagulation through replenishing the deficient clotting factors resulting from warfarin therapy.

Who Are The Companies Driving Activity In The Kcentra Market?

Major companies operating in the kcentra market are CSL Behring

Get The Full Kcentra Market Report:

https://www.thebusinessresearchcompany.com/report/kcentra-global-market-report

Which Region Leads The Kcentra Market In Overall Market Size?

North America was the largest region in the kcentra market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kcentra market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Kcentra Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/kcentra-global-market-report

Browse Through More Reports Similar to the Global Kcentra Market 2026, By The Business Research Company

Inductor Market Market Report 2026

https://www.thebusinessresearchcompany.com/report/inductor-market-global-market-report

Potassium Iodide Market Report 2026

https://www.thebusinessresearchcompany.com/report/potassium-iodide-global-market-report

Automotive Silicone Market Report 2026

https://www.thebusinessresearchcompany.com/report/automotive-silicone-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795